The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
It has become evident that the tumor microenvironment plays a pivotal role in the maintenance of cancerous growth. One of the acquired functions of the tumor microenvironment is the suppression of immune responses. Indeed, blocking the inhibitory pathways operational in the microenvironment results...
Main Authors: | Tel, Jurjen, Hato, Stanleyson V., Torensma, Ruurd, Buschow, Sonja I., Figdor, Carl G., Lesterhuis, W. Joost, de Vries, I. Jolanda M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378839/ |
Similar Items
-
STATing the importance of immune modulation by platinum chemotherapeutics
by: Hato, Stanleyson V., et al.
Published: (2012) -
Harnessing human plasmacytoid dendritic cells as professional APCs
by: Tel, Jurjen, et al.
Published: (2012) -
Naturally circulating dendritic cells to vaccinate cancer patients
by: Bol, Kalijn F., et al.
Published: (2013) -
Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
by: Vasaturo, Angela, et al.
Published: (2013) -
Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
by: Di Blasio, Stefania, et al.
Published: (2016)